Young Investigator Award

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this research grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

The Young Investigator Award (YIA) is a one-year research grant totaling $50,000, paid in two increments to the awardee’s institution. The applicant must be a physician (MD, DO, or international equivalent) who is currently within the last two years of his/her final subspecialty training at an academic medical institution at the time of grant submission. Applicants should be planning an investigative career in clinical oncology.

The 2015 YIA application cycle is now closed.  Please read the most recent 2015 Request for Proposals (RFP) for additional information about the YIA program. 

2015 YIA Supporters:

Boehringer Ingelheim Pharmaceuticals, Inc.
Eisai Inc.
Ethicon Endo-Surgery, Inc.
Genentech BioOncology™
Gilead Sciences, Inc.

Incyte Corporation 
Janssen Biotech, Inc.
 Merck Oncology
Takeda Oncology
Onyx Pharmaceuticals
Pfizer Oncology
Strike 3 Foundation


Evelyn H. Lauder Young Investigator Award
Endowment Fund

The Sally Gordon Young
Investigator Award Endowment Fund

The John R. Durant, MD, Young Investigator Award
Endowment Fund

This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments website. More information about the Sunshine Act and CMS Open Payments program can be found here.